Introduction
Chapter A.4
2017 edition
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...f their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all the unwanted effects of medications are mentioned.
more
Harm reduction: evidence, impacts and challenges
-10-
Developmental disorders
Chapter C.3
Externalising disorders
Chapter D.3
Mood disorders
Chapter E.4
2018 edition
Other disorders Chapter H.1
Psychatry & Pediatrics
Chapter I.3
Miscellaneous
Chapter J.6
Attention-Deficit/Hyperactivity Disorder
Advocacy ,Social Mobilization ,Behavior Change Communications
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
DHS Further Analysis Reports No. 115
Suicides take a high toll. Over 800 000 people die by suicide every year and it is the second leading cause of
death in 15-29-year-olds. Most suicides occur in low- and middle-income countries where resources
and services, if they do exist, are often scarce and limited for early identification, tr...eatment and support of
people in need. These striking facts and the lack of implemented timely interventions make suicide a serious
global public health problem that needs to be tackled urgently.
more